PAPILLON

NCT04538664 📎

Regimen

Experimental
amivantamab + carbo+pem
Control
carbo+pem

Population

EGFR exon 20 insertion advanced NSCLC 1L

Key finding

mPFS 11.4 vs 6.7 mo, HR 0.40 (0.30-0.53); first 1L for EGFR ex20

Source: PMID 37870976

Timeline

  • Enrollment start: 2020-10-13 📎

Guideline citations

  • NCCN NSCLC Version 5.2026 (p.205)
  • CSCO NSCLC 2025 ⚠️ OCR source